Hydrocortisone
Pharmaceutical forms
Ointment
Country lists
ATC N/A
Composition 1% (acetate)
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
13.3. Anti-inflammatory and antipruritic medicines
  • This medicine has the best evidence for effectiveness and safety.

Chile
Essential and Prioritized Medications
  • No observations
Powder for injection
Country lists
ATC N/A
Composition 100 mg (as sodium succinate) in vial
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
03. Antiallergics and medicines used in anaphylaxis
  • No observations
WHO Model List of Essential Medicines
8.3. Hormones and antihormones
  • No observations
PAHO Strategic Fund Medicine List
10. Antiallergics and medicines used in anaphylaxis
  • No observations
Bolivia
LINAME 2011 - 2013
  • No observations
Peru
03. Anti-Allergics and Medications for Anaphylaxis
  • No observations
Peru
18.1 Adrenal Hormones and Synthetic Substitutes
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Colombia
3.1 Systemic Corticosteroids
  • No observations
Cream
Country lists
ATC N/A
Composition 1% (acetate)
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
13.3. Anti-inflammatory and antipruritic medicines
  • This medicine has the best evidence for effectiveness and safety.

Bolivia
LINAME 2011 - 2013
  • No observations
Peru
13.3 Anti-Inflammatories & Anti-Pruritics
  • No observations
Colombia
10.5 Corticosteroids
  • No observations
Retention enema
Country lists
ATC N/A
Composition N/A
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
17.3. Anti-inflammatory medicines
  • This medicine has the best evidence for effectiveness and safety.

Suppository
Country lists
ATC N/A
Composition 25 mg (acetate)
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
17.3. Anti-inflammatory medicines
  • No observations
Tablet
Country lists
ATC N/A
Composition 5 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
18.1. Adrenal hormones and synthetic substitutes
  • No observations
Tablet
Country lists
ATC N/A
Composition 10 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
18.1. Adrenal hormones and synthetic substitutes
  • No observations
Tablet
Country lists
ATC N/A
Composition 20 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
18.1. Adrenal hormones and synthetic substitutes
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Cuba
18.1 Hormonas adrenales y sustitutivos sintéticos
  • No observations
Lotion
Country lists
ATC N/A
Composition 0.5% (acetate)
Observations for this pharmaceutical form can be found on the lists:
Colombia
10.5 Corticosteroids
  • No observations
Injection
Country lists
ATC N/A
Composition 250 mg (as sodium succinate)
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Powder for injection
Country lists
ATC N/A
Composition 500 mg (succinate)
Observations for this pharmaceutical form can be found on the lists:
Chile
Essential and Prioritized Medications
  • No observations
Powder for injection
Country lists
ATC N/A
Composition 100 mg (sodium succinate) in 10-mL vial
Observations for this pharmaceutical form can be found on the lists:
Cuba
18.1 Hormonas adrenales y sustitutivos sintéticos
  • No observations
Powder for injection
Country lists
ATC N/A
Composition 500 mg (sodium succinate) in 15-mL vial
Observations for this pharmaceutical form can be found on the lists:
Cuba
18.1 Hormonas adrenales y sustitutivos sintéticos
  • No observations